February, 2025

As of Q4 2024, the median transaction value in healthcare was $61 million. As of Q4 2024, strategic buyers accounted for 92% of transactions.

Select recent notable publicly announced M&A transactions:

–Suven Pharmaceuticals Limited closed its acquisition of NJ BIO for $64 million in December 2024.

–Novartis AG closed its acquisition of Kate Therapeutics for $1.1 billion in November 2024.

–Cencora closed its acquisition of Retina Consultants of America for $5.1 billion in November 2024.

–Francisco Partners Management closed its acquisition of Advanced MD for $1.1 billion in October 2024.

–AbbVie closed its acquisition of Aliada Therapeutics for $1.4 billion in October 2024.

    Download Report